London-based Perceptic, which says its end-to-end AI platform for drug development is being used by top pharmaceuticals, raised a $12M seed led by Accel (Jeremy Kahn/Fortune)

Jeremy Kahn / Fortune:
London-based Perceptic, which says its end-to-end AI platform for drug development is being used by top pharmaceuticals, raised a $12M seed led by Accel  —  A trio of former Palantir executives who helped spearhead that company's Life Sciences practice have founded a startup called Perceptic …

from Techmeme https://ift.tt/0phG3xt

Share this: